Misoprostol in Office Hysteroscopy and Endometrial Biopsy

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Office Hysteroscopy and Endometrial Biopsy

In brief

We hypothesize that use of vaginal misoprostol will help in reducing the pain scores when used prior to concurrent office hysteroscopy and endometrial biopsy in a particular subgroup of women who are anticipated to require cervical dilatation.

Key facts

Study ID

NCT03547778

Run by

University of South Florida

People needed

0

Starts

2018-09-01

Expected to finish

2020-03-25

Last updated by the study team

2021-06-18

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All consecutive female patients aged 18-70 years presenting to the Center for successive OH and EMB with the ability to provide written informed consent and meets at least one of the criteria mentioned below:
• Previous cesarean section
• Nulliparous
• Postmenopausal
• Previous loop electrosurgical excision procedure (LEEP) or cone biopsy
• Previous myomectomy

You may not qualify if…

• Premenopausal multiparous women with no prior surgeries performed on the uterus.
• Patients unable to provide informed consent
• Patients visiting the fibroid and endometriosis center with abnormal uterine bleeding, infertility or for preoperative evaluation; however, OH and EMB is not required for their evaluation based on their providers' clinical judgment.
• Patients with genital tract lesions.

Where it is running

• University of South Florida, Department of Obstetrics and Gynecology — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.